Document Detail


Intracranial Hemorrhage Requiring Surgery in Neurosurgical Patients Given Ketorolac: A Case-Control Study Within a Cohort (2001-2010).
MedLine Citation:
PMID:  23302965     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND:Ketorolac tromethamine (ketorolac) is a nonsedating drug with potent analgesic and moderate anti-inflammatory activity, which does not increase the sedation level. The safety of ketorolac with respect to risk of bleeding has been demonstrated in large numbers of patients undergoing general surgery, yet comparable safety data for neurosurgical patients are lacking. We studied the risk of symptomatic bleeding requiring surgery in patients undergoing elective neurosurgical procedures who received ketorolac as analgesic therapy.METHODS:We established a cohort of patients who had elective intracranial procedures from January 2001 to August 2010 (excluding patients with urgent surgery, coagulopathy, history of anticoagulant or nonsteroidal, anti-inflammatory drug therapy) and verified the occurrence of postcraniotomy intracranial hemorrhage (ICH; detected by computed tomography and requiring surgery) in patients who received or did not receive ketorolac. Then, to control for potential confounders, we conducted a "nested" case-control study within the cohort: cases were defined as patients with ICH; controls were patients without ICH matched in a 2:1 ratio.RESULTS:The cohort included 4086 craniotomy patients (mean age, 52.4 ± 14.3 years, 2124 male, 52%). Of the 1571 patients who received ketorolac (mean dosage, 50 ± 15 mg/d), 8 (0.5%) suffered ICH; of the 2515 patients who did not receive ketorolac, 35 (1.3%) had ICH (relative risk, 0.37; 95% confidence interval, 0.17-0.79; P = 0.007). In the nested case-control study, the adjusted odds ratio for ketorolac administration between the 2 groups was 1.09 (95% confidence interval, 0.35-3.44; P = 0.88).CONCLUSION:Although the adjusted estimate for risk of symptomatic bleeding requiring surgery and ketorolac use is very close to the null effect, it may be not reproducible, and the width of the confidence interval is not conclusive evidence of the safety of ketorolac after elective neurosurgical procedures.
Authors:
Giuseppina Magni; Italia La Rosa; Guido Melillo; Damiano Abeni; Helssy Hernandez; Giovanni Rosa
Related Documents :
8712425 - Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic ch...
1544195 - Ineffectiveness of acupuncture and droperidol in preventing vomiting following strabism...
7485935 - A double-blind randomized controlled trial of ginger for the prevention of postoperativ...
10087725 - Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in...
9462385 - Popliteal vein reflux reduces the healing of chronic venous ulcer.
9486905 - Vocal evaluation of thyroplasty type i in the treatment of nonparalytic glottic incompe...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-9
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  -     ISSN:  1526-7598     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the *Department of Anesthesia and Intensive Care, Policlinico Umberto 1, University of Rome, La Sapienza, Rome; and †Istituto Dermopatico dell'Immacolata IRCCS, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Isometric Force Dynamometer Is Superior to Bromage Score in Prediction of Patients' Ambulation After...
Next Document:  Physical Exercise Induces Excess Hsp72 Expression and Delays the Development of Hyperalgesia and All...